General

Cell Line

hPSCreg name MDCi233-A
Cite as:
MDCi233-A (RRID:CVCL_B5J0)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
INSRMi019-A
(PC129K8)
Donor diseases:
myofibrillar myopathy 1
INSRMi020-A
(PC130k2c)
Donor diseases:
myofibrillar myopathy 1
MRIi027-A
(DMD 01)
Donor diseases:
Duchenne muscular dystrophy
USFi001-A
(1CN1.5)
Donor diseases:
Friedreich Ataxia
INSRMi012-C
(PC173T19)
Donor diseases:
myofibrillar myopathy 1
INSRMi013-A
(PC179c1)
Donor diseases:
myofibrillar myopathy 1
CMCi002-A
(CMC-GIT-001)
Donor diseases:
Gitelman Syndrome
FJMUUHi001-A
Donor's gene variants:
PARK7
Donor diseases:
Parkinson's disease 7
BIHi002-A
Donor's gene variants:
CLCN7, CLCN7
Donor diseases:
autosomal recessive osteopetrosis 4
XMDYYYi001-A
(BDU-iPSCs)
Donor diseases:
Becker muscular dystrophy
IGIBi001-A
(SCP28)
Donor diseases:
Sickle cell anemia
BCHNi001-A
(BCHi001-A)
Donor diseases:
Bardet-Biedl Syndrome
CUIMCi005-A
(BB#2, BB9068#2)
Donor diseases:
Stargardt Disease
SCTCi014-A
(IPS17-00056)
Donor diseases:
Age-Related Macular Degeneration
MUBi002-A
(CF 001)
Donor diseases:
Cystic fibrosis
SCTCi012-A
(IPS19-00027)
Donor diseases:
age-related macular degeneration
SCTCi013-A
(IPS19-00053)
Donor diseases:
age-related macular degeneration
KMUGMCi005-A
(KMUGMCi005TMC8, KN627)
Donor diseases:
Epidermodysplasia Verruciformis
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
MMCi001-A
(MMC-iPSC-052B-02)
Donor diseases:
Deafness, Autosomal Recessive 1A
AIBNi016-A
(SPG2-S376C1)
Donor diseases:
hereditary spastic paraplegia 56
FAMRCi005-A
(LMNA B4)
Donor's gene variants:
LMNA
Donor diseases:
myopathy
atrioventricular block
Paroxysmal ventricular tachycardia
FAMRCi005-B
(LMNA B5)
Donor's gene variants:
LMNA
Donor diseases:
myopathy
atrioventricular block
Paroxysmal ventricular tachycardia
FAMRCi006-A
(LMNA T3)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
FAMRCi006-B
(LMNA T4)
Donor's gene variants:
LMNA
Donor diseases:
Emery-Dreifuss Muscular Dystrophy
Dilated Cardiomyopathy
KSCBi006-A
(KNIH-OI001i-A)
Donor's gene variants:
COL1A1
Donor diseases:
osteogenesis imperfecta type 1
ITXi013-A
(PT-R406W)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
ITXi013-B
(IC-R406)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
CMCi001-A
(CMC-KIN-hiPSC)
Donor diseases:
karyomegalic interstitial nephritis
PFIZi023-A
(B217c8)
Donor's gene variants:
GPR56, GPR56
Donor diseases:
Bilateral Frontoparietal Polymicrogyria
HEBHMUi012-A
Donor diseases:
Hypertension
BBANTWi010-A
(iPSC_PBMC_LDS_TGFB3_KE2M_C9)
Donor diseases:
Loeys-Dietz syndrome 5
Last update 29th July 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Max Delbrück Center Berlin Buch (MDC)
Derivation country Germany

External Databases

BioSamples SAMEA9422207
Cellosaurus CVCL_B5J0
Wikidata Q110433024

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed
Additional restrictions:

Additional donor consent will be obtained, prior to distribute the hiPSC lines to third parties.

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 30-34

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Limb-Girdle Muscular Dystrophy Type 2B
  • LGMD2B
  • Autosomal Recessive Muscular Dystrophy Limb-Girdle 2
  • LGMDR2
show more synonyms
Genetic variants
2p13.2
NM_001130987:c.1106T>C
NP_001124459:p.Leu369Pro
Heterozygous
2p13.2
NM_001130987:c.5302-5328delCGGCCCCTCTACAGCCCCCTGCAGCCA
NP_001124459:p.Arg1768_Pro1776del
Heterozygous

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
46, XY
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA9422208

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Yes
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Does consent expressly permit collection of genetic information? Yes
Does consent expressly permit storage of genetic information? Yes
Does consent prevent dissemination of genetic information? No
Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? Yes
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? Yes
Please describe how access is provided: By contacting an authorized medical doctor from the Charité University Medicine Outpatient Clinic for Muscle Disorders (Lindenberger Weg 80, 13125 Berlin, Germany)
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethics Committee of Charité Universitätsmedizin Berlin
Approval number EA2/175/17
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Ethics Committee of Charité Universitätsmedizin Berlin
Approval number EA2/175/17
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Thermo Fisher Scientific (Sendai 2.0 Reprogramming Kit)
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC
Age of donor (at collection) 30-34
Collected in 2020

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
PCR
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Selection criteria for clones Morphology (well-defined colony borders, packed colony morphology and no signs of spontaneous differentiation)
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 5 %
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
SOX2
Yes
NANOG
Yes
TRA 1-60
Yes
SSEA-4
Yes
SSEA-1
No
Morphology pictures
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
CXCR4
Yes
Sox17
Yes
Morphology
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
CD140b
Yes
CD144
Yes
Morphology
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
PAX6
Yes
SOX2
Yes
Morphology

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Passage number: 8
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)